ONC FY 2017 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

FY 2017 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$238M+22179.2% YoY

Gross Profit

-$36M-14.9% margin

Operating Income

-$98M-41.3% margin

Net Income

-$93M-39.1% margin

EPS (Diluted)

$-2.21

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

-$46M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$362M

Stockholders' Equity

$684M

Cash & Equivalents

$240M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$238M	$1M	+22179.2%
Gross Profit	-$36M	-$97M	+63.3%
Operating Income	-$98M	-$117M	+15.9%
Net Income	-$93M	-$119M	+21.9%